| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | 3,000,000 | 707,220,000 | 28.68% | Put | |
| 2 | TEVA PHARMACEUTICAL INDS LTD | 5,216,450 | 167,396,000 | 6.79% | ||
| 3 | MYLAN N V | 4,145,889 | 161,648,000 | 6.56% | ||
| 4 | GILEAD SCIENCES INC | 1,900,000 | 129,048,000 | 5.23% | ||
| 5 | NEKTAR THERAPEUTICS COM | 5,400,000 | 126,738,000 | 5.14% | ||
| 6 | ALLERGAN PLC | 435,750 | 104,109,000 | 4.22% | ||
| 7 | MYRIAD GENETICS INC | 4,325,000 | 83,040,000 | 3.37% | ||
| 8 | GENOMIC HEALTH INC COM | 2,458,100 | 77,406,000 | 3.14% | ||
| 9 | BROOKDALE SR LIVING INC | 5,500,000 | 73,865,000 | 3.00% | ||
| 10 | VERTEX PHARMACEUTICALS INC | 650,000 | 71,078,000 | 2.88% | ||
| 11 | GILEAD SCIENCES INC | 1,000,000 | 67,920,000 | 2.75% | Call | |
| 12 | SELECT MED HLDGS CORP COM | 5,000,000 | 66,750,000 | 2.71% | ||
| 13 | BIOVERATIV INC | 1,100,000 | 59,906,000 | 2.43% | ||
| 14 | LivaNova PLC | 1,200,000 | 58,812,000 | 2.39% | ||
| 15 | ORTHOFIX INTL N V | 1,500,000 | 57,225,000 | 2.32% | ||
| 16 | ENDO INTL PLC | 5,052,000 | 56,380,000 | 2.29% | ||
| 17 | PERRIGO CO PLC | 808,200 | 53,656,000 | 2.18% | ||
| 18 | CARDIOVASCULAR SYS INC DEL COM | 1,750,000 | 49,481,000 | 2.01% | ||
| 19 | ABBOTT LABS | 1,000,000 | 44,410,000 | 1.80% | ||
| 20 | ENDOLOGIX INC | 6,000,000 | 43,440,000 | 1.76% | ||
| 21 | ALKERMES PLC | 725,000 | 42,413,000 | 1.72% | ||
| 22 | SAREPTA THERAPEUTICS INC | 1,350,000 | 39,960,000 | 1.62% | ||
| 23 | INVITAE CORP | 2,398,123 | 26,523,000 | 1.08% | ||
| 24 | SYNERON MEDICAL LTD | 2,347,593 | 24,767,000 | 1.00% | ||
| 25 | PUMA BIOTECHNOLOGY | 650,000 | 24,180,000 | 0.98% | ||
| 26 | BIOSCRIP INC | 10,180,000 | 17,306,000 | 0.70% | ||
| 27 | PTC THERAPEUTICS INC | 1,250,000 | 12,300,000 | 0.50% | ||
| 28 | BIOLASE INC | 5,332,394 | 7,199,000 | 0.29% | ||
| 29 | Arena Pharmaceuticals, Inc | 4,250,000 | 6,205,000 | 0.25% | ||
| 30 | Atara Biotherapeutics Inc | 125,000 | 2,569,000 | 0.10% | ||
| 31 | TARGACEPT INC | 1,684,799 | 1,685,000 | 0.07% | PRN | |
| 32 | DEXTERA SURGICAL INC | 837,483 | 888,000 | 0.04% | ||
| 33 | BIOLASE INC | 1,841,173 | 0 | 0.00% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001654954-17-004694, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
